|
|
 |
|
Viewing report
|
|
|
|
Forest Laboratories, Inc. (FRX) - Financial and Strategic SWOT Analysis Review
GlobalData, April 2012, Pages: 47
Forest Laboratories, Inc. (FRX) - Financial and Strategic SWOT Analysis Review
Summary
Forest Laboratories, Inc. (Forest) is a pharmaceutical company focused on the development, manufacture and sale of branded forms of ethical drug products. It develops and manufactures products for treating several therapeutic indications namely, cardiovascular, central nervous system, endocrinology, obstetrics, gynecology, pain management and respiratory diseases. Forest is also developing several product candidates currently in various stages of development, targeting a wide range of therapeutic areas. The company through its direct and indirect sales force in the US region, markets products directly to physicians, pharmacies, hospitals, managed care and other healthcare organizations. Its principal customers include, AmeriSource Bergen Corporation, McKesson Drug Company and Cardinal Health, Inc. Forest is headquartered in New York, the US.
Forest Laboratories strategically focuses on developing partnerships with pharmaceutical and biotech companies to develop marketed products, license new products and to acquire new products at every stage in the development process.
Forest Laboratories, Inc. Key Recent Developments
Mar 15, 2012: Amerigen Announces ANDA Filing And BYSTOLIC Patent Challenge
Mar 14, 2012: Watson Confirms BYSTOLIC Patent Challenge
Jan 17, 2012: Forest Laboratories Reports Revenue Of $1.2 Billion In Q3 Fiscal 2012
Oct 18, 2011: Forest Laboratories Reports Total Revenue Of $1.17 Billion In Q2 Fiscal 2012
Jul 19, 2011: Forest Laboratories Reports Total Revenues Of $1.1 Billion For Q1 Fiscal 2012
This comprehensive SWOT profile of Forest Laboratories, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Customers who bought this item also bought
Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review
Watson Pharmaceuticals, Inc. (WPI) - Financial and Strategic SWOT Analysis Review
GlaxoSmithKline plc (GSK) - Financial and Strategic SWOT Analysis Review
Becton, Dickinson and Company (BDX) - Financial and Strategic SWOT Analysis Review
Hospira, Inc. (HSP) - Financial and Strategic SWOT Analysis Review
Alexza Pharmaceuticals, Inc. (ALXA) - Financial and Strategic SWOT Analysis Review
Bio-Reference Laboratories, Inc. (BRLI) - Financial and Strategic SWOT Analysis Review
Life Technologies Corporation (LIFE) - Financial and Strategic SWOT Analysis Review
Covidien plc (COV) - Financial and Strategic SWOT Analysis Review
ResMed Inc. (RMD) - Financial and Strategic SWOT Analysis Review
|
|
|
|
